Skip to main content
Vivatmo

Vivatmo pro for professionals

An intuitive and maintenance-free device for practices and clinics

Vivatmo pro

Vivatmo pro was specially developed for professional use in doctors’ practices and clinics. Thanks to its simple measuring procedure and intuitive use, it can be smoothly integrated into the workflow of professional practices. Both physicians and patients benefit from the more efficient patient care.

These features make Vivatmo pro a unique solution:
Compact and mobile measuring unit, maintenance-free, cordless, and easy to use.

The benefits of Vivatmo pro

Easy measurement thanks to intuitive user guidance

Results are available immediately following the measurement

Flexibility of use thanks to cordless and mobile handheld

Optimum and direct integration into practice workflows

Vivatmo in the doctor’s practice
How you can benefit from Vivatmo

What does Vivatmo pro detect?

You can use Vivatmo to determine the level of the established biomarker nitric oxide (NO) in exhaled air and thus monitor allergic airway inflammation in your patients.

Vivatmo pro

How does Vivatmo measure FeNO?

Your patient breathes calmly into the handheld through the disposable mouthpiece. After successful measurement, the result is available within a few seconds. FeNO measurement is quick, easy, repeatable, and non-invasive for your patients.

Vivatmo pro - FeNO measurement

What does the FeNO value tell you?

FeNO is formed in the respiratory tract by inflammatory cells. The NO concentration in the exhaled air therefore reflects the degree of inflammation in the respiratory tract – the more inflammatory cells there are, the more NO is produced. The NO concentration in exhaled air is measured in parts per billion (ppb). According to the asthma guidelines, increased FeNO values indicate allergic inflammation and thus support the diagnosis of allergic asthma.1

Vivatmo pro with results

What are the advantages of FeNO measurement for you and your patients?

Using the FeNO value, you can detect allergic inflammation of the respiratory tract in your patients and closely monitor the progression of the inflammation, also during therapy. National and international guidelines recommend FeNO measurements for diagnosis, therapy management, and monitoring of asthma patients.1,2,3 Increased FeNO values indicate a worsening of the course of the disease even before a conspicuous pulmonary function test result and therefore allow early therapeutic countermeasures to be taken.4

Vivatmo pro doctor and patients

The goal of good asthma therapy is for the patient, in spite of the illness and with medication at the lowest possible dose, to be able to do everything that a non-asthmatic individual can do. In other words: to live a normal life.

Prof. Dr. med. Herth, University of Heidelberg, Germany 5

1 Buhl et al. Pneumologie 2017; 71: 849–919

2 Dweik et al. Am J Respir Crit Care Med 2011;184: 602–15

3 NICE Guideline Asthma - diagnosis and monitoring (November 2017, https://www.nice.org.uk/guidance/ng80/evidence/full-guideline-asthma-diagnosis-and-monitoring-pdf-4656178047)

4 Bodini et al. J Breath Res. 2017; 27;11(4)

5 Prof. Dr. med. Felix Herth, Medical Director of Thoraxklinik Heidelberg, University Hospital Heidelberg, 2016

Do you have any questions or are you interested in Vivatmo pro?

Here you will find your suitable contact person.

To Distribution partner overview

Not all products are available in all regions. Check with your local representative for availability in specific markets.